Vaccines can temporarily raise blood sugar, and the effect is most relevant for people who already have diabetes. A systematic review of 24 studies on COVID-19 vaccination found that 21 of them reported some degree of blood glucose increase after the shot, while only three found no effect at all. For most people, any spike is mild and short-lived, but the reality is more nuanced than a simple yes or no, particularly when it comes to who is affected, how much their glucose shifts, and whether the change actually matters clinically.
Why Vaccines Nudge Blood Sugar Upward
The core reason is inflammation. Every vaccine is designed to provoke an immune response, and that response releases a cascade of signaling molecules, including cytokines and stress hormones like cortisol and adrenaline. These hormones have a well-documented side effect: they make cells less responsive to insulin and prompt the liver to release stored glucose into the bloodstream. In a person without diabetes, the pancreas compensates by producing more insulin, and blood sugar stays roughly stable. In someone whose insulin production or sensitivity is already compromised, the extra demand can push glucose readings noticeably higher.
This is the same basic mechanism behind the blood sugar spikes people with diabetes experience during any illness, surgery, or period of physical stress. The body interprets the immune activation from a vaccine much the way it interprets a mild infection: it shifts into a metabolic “fight” mode that prioritizes fuel availability over tight glucose regulation. Stress hormones like catecholamines and glucocorticoids drive up insulin resistance and blood sugar, an adaptive response in a healthy person that can become problematic in someone already managing diabetes.
What the COVID-19 Vaccine Research Actually Found
The COVID-19 pandemic generated an unusual volume of research on this question, partly because millions of people with diabetes were vaccinated in a short window and many of them were already wearing continuous glucose monitors. That created a natural laboratory for studying the effect in real time.
A systematic review published in the World Journal of Diabetes examined 24 studies and found that the vast majority reported some increase in blood glucose following COVID-19 vaccination, though only three found no measurable effect. The review also noted that vaccination could cause a temporary perturbation of interstitial glucose in people with type 1 diabetes, with no meaningful difference between the AstraZeneca and Pfizer vaccines in terms of how much glucose was affected.1PubMed Central. Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review
However, when researchers pooled the data more rigorously through meta-analysis, the picture looked less alarming. A separate meta-analysis focused on people with type 1 diabetes found that COVID-19 vaccination caused a small decrease in time-in-range (the percentage of the day blood sugar stays within target) after both the first and second doses, but neither change reached statistical significance. Time above range, time below range, mean blood glucose, and glucose variability were also unaffected in statistically meaningful ways.2PubMed Central. Immediate impacts of COVID-19 vaccination on glycemic control in type 1 diabetes mellitus: a systematic review and meta-analysis In other words, the average effect across many people was small enough that it could have been due to chance.
A study of Arabic patients with type 1 diabetes added some texture to this. It found a modest but statistically significant decrease in glucose variability over the seven days following each dose, with no lingering effect at 14 days. Interestingly, the pattern differed slightly between vaccine types: the viral vector-based vaccine showed some effect on time-in-range and time-above-range, while the mRNA vaccine affected glucose variability but not those other metrics.3PubMed Central. Effect of COVID-19 vaccine on blood glucose metrics in Arabic people with type 1 diabetes The takeaway is that while individual people may notice a glucose bump, the group-level data suggests the effect is modest and resolves within a week or two.
People With Diabetes Are More Vulnerable, but Not Equally
Not everyone with diabetes experiences the same degree of glucose disruption after vaccination. The systematic review in the World Journal of Diabetes noted that the temporary glucose perturbation was more pronounced in patients taking oral diabetes medications combined with insulin, and also more noticeable in those with lower baseline HbA1c levels.1PubMed Central. Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review That second finding is somewhat counterintuitive: you might expect people with worse glucose control to be hit harder, but it appears that those with tighter control may actually see a more noticeable relative shift, possibly because their baseline is lower and any bump becomes proportionally more visible.
Research on COVID-19 mRNA booster vaccines and type 2 diabetes has raised additional concerns. A study published in MedComm found that patients with diabetes showed exacerbated risks of glucose intolerance and insulin resistance after mRNA booster shots, with significant elevations in HbA1c, a marker of insulin resistance called HOMA-IR, triglycerides, and the triglyceride-glucose index. Although fasting blood glucose itself did not change significantly, roughly two-thirds of the diabetes patients in the study showed impaired insulin sensitivity after the booster.4PubMed Central. SARS‐CoV‐2 Spike Protein as a Target of the COVID‐19 Vaccine Disrupts Insulin Signaling in Type 2 Diabetes That study also proposed a specific mechanism: the spike protein produced by the vaccine may interfere with insulin signaling pathways in people who already have type 2 diabetes.
For people without diabetes, the picture is different. The immune response still happens, and stress hormones still rise briefly, but a healthy pancreas compensates. Most people without a metabolic condition will never notice a change in how they feel after a vaccine on a blood sugar level, because the body handles the transient shift without any trouble.
Beyond COVID Vaccines
Most of the recent research has focused on COVID-19 vaccines because they were administered at massive scale during a period of intense scientific scrutiny. But the underlying mechanism applies to other vaccines too. Any vaccine that provokes a meaningful immune response will temporarily raise stress hormones and cytokine levels, and that can transiently affect glucose metabolism.
A case report published in Diabetes Spectrum described a 54-year-old man with type 2 diabetes who developed blood glucose levels exceeding 300 mg/dL within 24 hours of receiving a seasonal influenza vaccine, with no other changes to his diet, activity, or medications.5PubMed Central. Acute Hyperglycemia After Influenza Vaccination in a Patient With Type 2 Diabetes That is a single case report, not a controlled study, so it does not tell us how common such reactions are. But it illustrates that the flu shot can trigger the same inflammatory cascade in a susceptible individual. Healthcare providers who work with diabetes patients are generally aware of this possibility, which is why some recommend more frequent glucose monitoring around the time of any vaccination.
The broader principle is straightforward: any stressor that activates the immune system can temporarily raise blood sugar in people whose glucose regulation is already fragile. Vaccines are one such stressor, but so are common colds, dental infections, and even intense exercise. The vaccine just has the advantage of being a planned event, which means you can prepare for it.
Rare but Serious Glucose Emergencies
In extremely rare cases, COVID-19 vaccination has been linked to diabetic ketoacidosis (DKA) and a related emergency called hyperosmolar hyperglycemic state (HHS). These are situations where blood sugar climbs so high that the body begins breaking down fat for fuel (in DKA) or becomes severely dehydrated from excess urination (in HHS). Both are medical emergencies that require hospital treatment.
A case series published in the Journal of the Endocrine Society described three patients who developed HHS or DKA within 2 to 10 days of COVID-19 vaccination. All tested negative for active SARS-CoV-2 infection, and other common triggers were ruled out. Two of the three had previously diagnosed type 2 diabetes with moderately controlled HbA1c levels, while one was newly diagnosed during the hospitalization. All three responded to insulin treatment and were eventually able to return to oral diabetes medications, with insulin discontinued within eight weeks.6Journal of the Endocrine Society. Hyperglycemic Emergencies Associated With COVID-19 Vaccination: A Case Series and Discussion
A study examining DKA specifically in type 1 diabetes patients found that among those diagnosed with DKA, about a third had been vaccinated against COVID-19 within the preceding 29 days. Blood sugar and pH levels were significantly higher in the vaccinated group compared to unvaccinated patients who developed DKA from other causes.7PubMed Central. Diabetic Ketoacidosis After COVID-19 Vaccine in Patients with Type 1 Diabetes Mellitus A review in the World Journal of Diabetes acknowledged this potential connection but emphasized that such complications are “extremely rare.”8PubMed Central. COVID-19 vaccination and diabetic ketoacidosis
Context matters here. DKA and HHS can be triggered by many things: missed insulin doses, infections, surgery, certain medications, and heavy alcohol use. A vaccine adding one more trigger to an already-long list does not mean the vaccine is uniquely dangerous. It means that people at risk for these emergencies should be aware and keep closer watch on their glucose in the days following vaccination.
The Corticosteroid Wrinkle
One detail that sometimes muddies the picture is corticosteroid use around the time of vaccination. Some people take steroids (like dexamethasone or prednisone) for autoimmune conditions, allergies, or as premedication before certain medical procedures. Corticosteroids are potent blood sugar elevators. A study measuring glucose changes in patients who received corticosteroid premedication found that the average blood sugar rise was about 58 mg/dL within the first 24 hours, with diabetic patients seeing a mean maximal change of roughly 87 mg/dL compared to about 27 mg/dL in non-diabetic patients.9PubMed. Hyperglycemic consequences of corticosteroid premedication in an outpatient population
If someone happens to be taking corticosteroids around the time they get vaccinated, any blood sugar spike they observe may be partly or entirely driven by the steroid, not the vaccine itself. This is worth keeping in mind because people with chronic conditions that require steroid therapy are also more likely to be closely monitored for glucose changes. Disentangling the vaccine’s effect from the steroid’s effect can be difficult in individual cases.
Do Vaccines Cause Diabetes?
A temporary blood sugar increase after a vaccine is not the same thing as developing diabetes. This distinction matters because it touches on a long-running concern: whether childhood vaccines might cause type 1 diabetes. A large Danish study tracked over 700,000 children born between 1990 and 2000 across nearly five million person-years of follow-up. Type 1 diabetes was diagnosed in 681 of those children, and the researchers found no increased risk associated with any of the routine childhood vaccines examined, including those for Haemophilus influenzae type b, diphtheria-tetanus-polio, pertussis, measles-mumps-rubella, or oral polio.10PubMed. Childhood vaccination and type 1 diabetes The rate ratios for vaccinated versus unvaccinated children hovered close to 1.0 for every vaccine, meaning vaccinated children were no more likely to develop type 1 diabetes than unvaccinated children.
The COVID-19 pandemic did produce some reports of new-onset diabetes appearing shortly after vaccination, but establishing causation from case reports is tricky. COVID-19 infection itself is known to trigger new-onset diabetes in some people through direct damage to insulin-producing cells. Separating the vaccine’s effect from undiagnosed prior infection or coincidental autoimmune onset remains an active area of research. What the evidence does not support is the idea that routine vaccines are a meaningful cause of diabetes in children or adults.
Practical Steps for Managing Blood Sugar Around Vaccination
If you have diabetes and are due for any vaccine, the evidence suggests a few straightforward precautions. First, check your blood sugar more frequently in the 48 to 72 hours after the shot. Most of the glucose perturbation seen in studies resolves within about a week, with the biggest shifts happening in the first day or two. If you use a continuous glucose monitor, you already have real-time data; just pay closer attention to the trend arrows and overnight readings.
Second, stay hydrated and keep your usual diet and medication routine. Some people skip meals or change their eating patterns when they feel unwell after a vaccine, which can compound glucose instability. If you take insulin, have a plan with your doctor for making small dose adjustments in case readings run high for a few days. The goal is not to avoid vaccination; it is to manage the predictable bump rather than be caught off guard by it.
Third, know the warning signs of DKA and HHS. Persistent blood sugar above 300 mg/dL, nausea, vomiting, abdominal pain, rapid breathing, or extreme thirst that does not resolve with fluids all warrant urgent medical attention. These complications are rare, but they are also treatable when caught early.
Anxiety, Stress, and the Needle Itself
One underappreciated factor is the role of psychological stress in blood sugar spikes around vaccination. Fear of needles is far more common than most people realize, affecting millions of adults in the United States alone.11PubMed Central. Considering Needle Phobia among Adult Patients During Mass COVID-19 Vaccinations The acute anxiety associated with getting a shot triggers a stress response that releases the same catecholamines and cortisol involved in the immune response, potentially driving glucose up before the vaccine itself has even had time to provoke an immune reaction.12PubMed Central. Stress-Induced Diabetes: A Review
This means that some of the blood sugar elevation people attribute to the vaccine may actually be a stress response to the experience of being vaccinated. For someone with diabetes who monitors their glucose closely, a reading taken shortly after arriving at the pharmacy and sitting through a somewhat anxiety-inducing appointment might be higher than usual regardless of what was in the syringe. Relaxation techniques, distraction, and simply being aware that anxiety can push glucose up may help separate the psychological effect from the immunological one. It does not change the practical advice: monitor more closely and be ready to adjust. But it does suggest the vaccine itself may deserve less blame than it sometimes gets for the immediate post-shot reading on a glucose meter.